The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Immix Biopharma Inc (NASDAQ: IMMX) was $3.33 for the day, down -8.52% from the previous closing price of $3.64. In other words, the price has decreased by -$8.52 from its previous closing price. On the day, 0.68 million shares were traded. IMMX stock price reached its highest trading level at $3.58 during the session, while it also had its lowest trading level at $3.24.
Ratios:
Our analysis of IMMX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.23 and its Current Ratio is at 1.23. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.21.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 17 ’25 when Rachman Ilya M bought 2,500 shares for $2.02 per share. The transaction valued at 5,050 led to the insider holds 1,140,937 shares of the business.
Morris Gabriel S bought 2,600 shares of IMMX for $5,122 on Sep 16 ’25. The CFO now owns 290,659 shares after completing the transaction at $1.97 per share. On Jun 18 ’25, another insider, Rachman Ilya M, who serves as the CEO and Chairman of the company, bought 2,178 shares for $2.29 each. As a result, the insider paid 4,999 and bolstered with 1,138,437 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMMX now has a Market Capitalization of 110008264 and an Enterprise Value of 85422448.
Stock Price History:
The Beta on a monthly basis for IMMX is 0.34, which has changed by 1.2750001 over the last 52 weeks, in comparison to a change of 0.15566266 over the same period for the S&P500. Over the past 52 weeks, IMMX has reached a high of $4.05, while it has fallen to a 52-week low of $1.34. The 50-Day Moving Average of the stock is 31.14%, while the 200-Day Moving Average is calculated to be 50.84%.
Shares Statistics:
IMMX traded an average of 424.04K shares per day over the past three months and 959600 shares per day over the past ten days. A total of 28.41M shares are outstanding, with a floating share count of 16.20M. Insiders hold about 43.82% of the company’s shares, while institutions hold 8.28% stake in the company. Shares short for IMMX as of 1760486400 were 598715 with a Short Ratio of 1.41, compared to 1757894400 on 454735. Therefore, it implies a Short% of Shares Outstanding of 598715 and a Short% of Float of 2.77.
Earnings Estimates
The market rating for Immix Biopharma Inc (IMMX) is a result of the insights provided by 1.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.17 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$0.62 and -$0.73 for the fiscal current year, implying an average EPS of -$0.68. EPS for the following year is -$0.75, with 2.0 analysts recommending between -$0.69 and -$0.82.
